# Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department

> **NCT02248753** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 437 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Pharmacological cardioversion - Flecainide
- **PROCEDURE:** Electrical cardioversion
- **DRUG:** Metoprolol
- **DRUG:** Verapamil
- **DRUG:** Digoxin
- **DRUG:** Pharmacological cardioversion - Amiodarone

## Key facts

- **NCT ID:** NCT02248753
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2018-11
- **Final completion:** 2019-12
- **Target enrollment:** 437 (ACTUAL)
- **Last updated:** 2020-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02248753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02248753, "Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02248753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*